Please Wait
Applying Filters...
menu
    • menu
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

    Virtual Booth

    Contact Supplier

    Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Virtual Booth

    Contact Supplier

    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Menu

    Pomalidomide

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 78,757Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Darzalex Based Maintenance Shows Deep Responses In Multiple Myeloma
    Darzalex Based Maintenance Shows Deep Responses In Multiple Myeloma

    27 Sep 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/darzalex-daratumumab-based-maintenance-regimens-show-clinically-meaningful-deep-and-durable-responses-in-transplant-eligible-patients-with-newly-diagnosed-multiple-myeloma-302261304.html

    PR NEWSWIRE
    27 Sep 2024
    Share Share
    SciBase announces sale of Nevisense to NIH (US)
    SciBase announces sale of Nevisense to NIH (US)

    27 Sep 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/scibase-announces-sale-of-nevisense-to-nih-us-302261013.html

    PR NEWSWIRE
    27 Sep 2024
    Share Share
    Krka`s Pomalidomide Receives Approval in Europe
    Krka`s Pomalidomide Receives Approval in Europe

    24 Sep 2024

    // EMA

    https://www.ema.europa.eu/en/documents/overview/pomalidomide-krka-epar-medicine-overview_en.pdf

    EMA
    24 Sep 2024
    Share Share
    Legend Biotech Reports Positive OS Results From CARTITUDE-4 Trial
    Legend Biotech Reports Positive OS Results From CARTITUDE-4 Trial

    02 Jul 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/07/02/2907367/0/en/Legend-Biotech-Announces-Positive-Overall-Survival-Results-of-Landmark-Phase-3-CARTITUDE-4-Trial-in-Multiple-Myeloma.html

    GLOBENEWSWIRE
    02 Jul 2024
    Share Share
    Apotex'sGeneric Pomalidomide Receives Approval in US
    Apotex'sGeneric Pomalidomide Receives Approval in US

    11 Jun 2024

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210164

    FDA
    11 Jun 2024
    Share Share
    Pomavid®; Our dedication to shaping hope
    Pomavid®; Our dedication to shaping hope

    07 Jun 2024

    // PRESS RELEASE

    https://www.nanoalvand.com/index.php/en/blog-en/10-releases/34-pomavid-release

    PRESS RELEASE
    07 Jun 2024
    Share Share